About Bruker Corporation
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts. Address: 40 Manning Road, Billerica, MA, United States, 01821
Bruker Corporation News and around…
Latest news about Bruker Corporation (BRKR) common stock and company :
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2021 financial results on Monday, November 1, 2021, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends.
Investors in Bruker Corp (BRKR) saw new options begin trading this week, for the June 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings […]
Badger Meter (BMI) reports strong third-quarter 2021 results with net earnings and revenues increasing year over year, driven by healthy order momentum and higher adoption of digital solutions.
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Bruker Corp (BRKR) was identified as having a larger market cap than the smaller end of the S&P 500, for example BorgWarner Inc (BWA), according to The Online Investor. Click here to find out the top S&P 500 components ordered by average analyst rating » Market capitalization is an important data point for investors to keep an eye on, for various reasons..
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Russell 1000 Enhanced Equal Weight ETF (USEQ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $40.40 per unit.
Thermo Fisher's (TMO) wastewater surveillance method is set to identify asymptomatic carriers on college campuses to monitor regional spread among communities.
Today we're going to take a look at the well-established Bruker Corporation ( NASDAQ:BRKR ). The company's stock saw...
The heavy selling pressure might have exhausted for Bruker (BRKR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Bruker Corporation (Nasdaq: BRKR) today announced that it has received orders for two 1.1 GHz NMR Avance Neo systems from U.S. academic institutions funded by the National Science Foundation (NSF). NSF awarded the funds to establish the Network for Advanced NMR (NAN) linking three institutions including the University of Connecticut School of Medicine, the University of Georgia and University of Wisconsin–Madison. NAN is a novel consortium with the goal to establish a distributed network of ultra-high field NMR spectrometers that tackle important and diverse scientific problems and train the next generation of life and materials scientists.
Investors in Bruker Corp (BRKR) saw new options begin trading this week, for the November 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BRKR options chain for the new November 19th contracts and identified one put and one call contract of particular interest.
Symbols mentioned in this story: KOMP, BRKR, TDY, LC Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand..
Revenue expected to grow 19.10% this year and another 6.20% next year. Earnings estimated to increase 43.00% this year, an additional 16.10% next year.
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Wells Fargo Virtual Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer, and Falko Busse, President of the Bruker BioSpin Group, will participate in an analyst moderated question and answer session on behalf of the Company on Friday, September 10, 2021 at 9:20 AM Eastern Time.
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market ...
Investors are optimistic about Bruker (BRKR) on solid BSI Nano Group growth potential and raised 2021 financial guidance.
Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was ...
Pulled from Benzinga Pro data Bruker (NASDAQ:BRKR) posted a 3.93% decrease in earnings from Q1. Sales, however, increased by 2.9% over ...
Year-over-year improvement in segmental revenues in Q2 across all geographies exceeds Illumina's (ILMN) expectations.
Insulet (PODD) reports better-than-expected revenues for second-quarter 2021 on strong performance of Omnipod, both in U.S. and international markets.
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock. The dividend will be paid on September 17, 2021 to stockholders of record as of September 1, 2021.
Bruker (NASDAQ:BRKR) shares experienced unusual options activity on Tuesday. The stock price moved down to $81.64 following the option ...
Bruker (BRKR) reports better-than-expected revenues for the second quarter of 2021 on strong segmental performance driving the top line.
Bruker Corporation(NASDAQ: BRKR) Bruker reported that its second-quarterrevenues were up 34% Y/Y to $570.8 million, ...
Bruker (BRKR) delivered earnings and revenue surprises of 10.00% and 6.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of Bruker (NASDAQ:BRKR) fell in after-market trading after the company reported Q2 results. Quarterly Results Earnings per ...
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2021.
Bruker (BRKR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.